4.7 Review

Advances in the research of nano delivery systems in ischemic stroke

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

ROS-responsive 18β-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation

Lulu Jin et al.

Summary: Ischemic stroke is a serious cerebral vascular disease. The polarization of microglia, an important immune component in the central nervous system, is closely related to high mobility group box 1 (HMGB1). By designing reactive oxygen species (ROS) responsive polymer-drug conjugate nanoparticles, it is possible to manipulate microglia polarization and achieve excellent therapeutic efficacy in ischemic stroke treatment.

BIOACTIVE MATERIALS (2023)

Article Endocrinology & Metabolism

Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke

Alba Grayston et al.

Summary: This study utilized a new endovascular approach to deliver functionalized polymer nanocapsules to the mouse brain, enabling therapeutic magnetic targeting, magnetic resonance, and fluorescent imaging. The results demonstrated a significant advantage of intraarterial delivery in brain targeting in ischemic mice, with good safety profiles.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

Article Engineering, Biomedical

Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery

Shenqi Zhang et al.

Summary: Research has developed natural compound-derived nanoparticles that can be used both as a therapeutic agent for stroke treatment and as a carrier for efficient drug delivery to the brain, potentially improving stroke treatment.

BIOACTIVE MATERIALS (2022)

Review Engineering, Biomedical

Advances in nanomedicines for diagnosis of central nervous system disorders

Xun Zhang et al.

Summary: Despite advancements in medical services and lifespan, there has been a sharp increase in CNS disorders, posing challenges in diagnosis and delivery of diagnostic agents, especially across the blood-brain barrier. The use of nanomaterials is seen as a promising strategy to address these challenges, but further development is needed to overcome current obstacles in CNS diagnostics.

BIOMATERIALS (2021)

Article Clinical Neurology

Combination of Polyethylene Glycol-Conjugated Urokinase Nanogels and Urokinase for Acute Ischemic Stroke Therapeutic Implications

Ding Nan et al.

Summary: The study aimed to establish new urokinase-based therapeutics for ischemic stroke treatment, showing that formulations containing UK performed better within the time window, while those containing PEG-UK demonstrated sufficient thrombolytic efficiency beyond the time window. Further investigation revealed that the dual targeting delivery of UK in the PEG-UK+UK formulation was beneficial for stroke treatment.

TRANSLATIONAL STROKE RESEARCH (2021)

Article Nanoscience & Nanotechnology

pH-Responsive Multifunctional Theranostic Rapamycin-Loaded Nanoparticles for Imaging and Treatment of Acute Ischemic Stroke

Yan Cheng et al.

Summary: The study developed a pH-sensitive theranostic nanoplatform for the precise delivery of rapamycin to ischemic brain tissues, enhancing therapeutic accuracy and enabling multimodal imaging for drug distribution monitoring. The nanoparticles showed good stability and biocompatibility, with the potential for neuroprotection in rats with transient middle cerebral artery occlusion (tMCAO). This pH-sensitive multifunctional nanoplatform could be a promising solution for the accurate in vivo imaging and treatment of acute ischemic stroke and other diseases.

ACS APPLIED MATERIALS & INTERFACES (2021)

Review Pharmacology & Pharmacy

Targeting the blood-brain barrier for the delivery of stroke therapies

Anisha D'Souza et al.

Summary: This study discusses the viable strategy of targeting endothelial cells for drug delivery to facilitate neuroprotective effects, using BDNF as an example. It emphasizes the advances in cell-derived EVs for CNS targeting and drug delivery, as well as the potential of engineered EVs as an effective strategy to deliver drugs to the ischemic brain.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Engineering, Biomedical

Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy

Alina Zenych et al.

Summary: The development of fucoidan-functionalized hydrogel polysaccharide submicroparticles as a nanocarrier for targeted thrombolysis using alteplase has shown promising results in vitro and in vivo, demonstrating improved clot dissolution and reduced post-ischemic cerebral infarct lesions and blood-brain barrier permeability in a murine model of acute thromboembolic ischemic stroke.

BIOMATERIALS (2021)

Review Neurosciences

Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

Surojit Paul et al.

Summary: Stroke is a major cause of disability and death globally, with an increasing incidence particularly in younger age groups and low to middle-income countries. While treatment options are limited, advancements in recanalization therapy have shown promise in helping patients recover from ischemic stroke. Development of neuroprotective agents for acute ischemic stroke is urgently needed to protect the brain, extend the therapeutic time window, and improve outcomes.

EXPERIMENTAL NEUROLOGY (2021)

Article Nanoscience & Nanotechnology

The colossal role of H-MnO2-PEG in ischemic stroke

Song-Bin Yang et al.

Summary: This study reports the synthesis and functionalization of monodisperse hollow structured MnO2, which showed protective effects on ischemic stroke after successive modification.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)

Article Engineering, Biomedical

T Cell-Mediated Transport of Polymer Nanoparticles across the Blood-Brain Barrier

Maxime Ayer et al.

Summary: This study demonstrates the feasibility of using activated effector/memory CD4(+) helper T cells as carriers for delivering polymer nanoparticles across the blood-brain barrier. In vitro and in vivo experiments confirm the ability of these cells to transport nanoparticles across the barrier, showing the potential for brain delivery in allogeneic hosts.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Pharmacology & Pharmacy

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies

Liang Han et al.

Summary: This review focuses on nanoscale brain-targeting drug delivery strategies designed based on blood-brain barrier (BBB) alterations and their applications in various brain diseases. However, advances on optimization of small molecules for BBB crossing and non-systemic administration routes such as intranasal treatment are not included in this review.

ACTA PHARMACEUTICA SINICA B (2021)

Article Chemistry, Multidisciplinary

Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy

Youngki Lee et al.

Summary: Polyamidoamine dendrimer, specifically PG2HR with histidine and arginine conjugation, has shown higher gene delivery efficiency and lower cytotoxicity compared to commonly used PG6. It has demonstrated potential for gene therapy of inflammatory diseases, including ischemic stroke, due to its improved cellular uptake and endosomal escape.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Biotechnology & Applied Microbiology

Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke

Yanyun Wang et al.

Summary: The developed monocyte membranes-coated rapamycin nanoparticles (McM/RNPs) have shown promise in alleviating ischemia/reperfusion injury by reducing inflammation and inhibiting cell proliferation. These nanoparticles demonstrated improved targeting and therapeutic effects in animal models, with good safety profiles observed in vivo studies.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Immunology

Nanoparticles of resveratrol attenuates oxidative stress and inflammation after ischemic stroke in rats

Mohammad Ashafaq et al.

Summary: Nanoparticles of resveratrol show neuroprotective effects in a rat model of stroke, reducing infarction, improving neurological function, decreasing oxidative stress, and inhibiting the activities of enzymes and cytokines.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Cell Biology

Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy

Karishma Dhuri et al.

Summary: The use of anti-miR oligonucleotides delivered by nanoparticles successfully reduced levels of miR-141-3p after ischemic stroke, demonstrating potential as a treatment option for long-term disability.

CELLS (2021)

Review Neurosciences

An updated review of autophagy in ischemic stroke: From mechanisms to therapies

Xiaoyu Wang et al.

Summary: Autophagy plays a crucial role in brain pathology after ischemic stroke, making its regulation a potential therapeutic target.

EXPERIMENTAL NEUROLOGY (2021)

Review Pharmacology & Pharmacy

Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics

Amir Ajoolabady et al.

Summary: Stroke is the second leading cause of death and a major cause of disability worldwide, with the majority of cases being ischemic. Recent research has highlighted the important role of autophagy in the pathogenesis of ischemic stroke. Autophagy serves as an adaptive mechanism for cell response to stroke, but excessive induction may be harmful.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Engineering, Biomedical

pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic Stroke

Hang Yang et al.

Summary: This study introduces a dual-targeted therapeutic strategy for improving drug delivery in ischemic brain, utilizing PHSRN peptides for targeted delivery and SAG@PHSRN-HES nanoparticles to release more SAG in the acidic environment of ischemic brain tissue. The synergistic mechanisms of PHSRN and SAG hold promise in promoting angiogenesis and improving neurological function recovery, suggesting potential for treating cerebral infarction patients.

ADVANCED HEALTHCARE MATERIALS (2021)

Article Biotechnology & Applied Microbiology

Integrin α2β1-targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy

Chiun-Wei Huang et al.

Summary: The study demonstrated that the integrin alpha 2 beta 1-targeting H-ferritin (2D-HFn) based drug delivery system significantly increased drug loading capacity and tumor targeting capability, showing promising results in inhibiting glioma progression. This innovative technique may have great potential for more accurate brain tumor targeting and precision treatment arrangements in translational medicine.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Pharmacology & Pharmacy

Recent advances in nanomedicines for the treatment of ischemic stroke

Chao Li et al.

Summary: Ischemic stroke is a cerebrovascular disease caused by interrupted blood supply to the brain, leading to cell death and brain infarction. Nanomedicine offers new treatment possibilities by improving drug behavior and reducing side effects.

ACTA PHARMACEUTICA SINICA B (2021)

Review Engineering, Biomedical

Recent advances in the development of nanomedicines for the treatment of ischemic stroke

Xing Tian et al.

Summary: This review focuses on the potential applications of nanotechnology in stroke treatment. It discusses the main molecular pathological mechanisms of ischemic stroke, the role of the blood-brain barrier, and summarizes the challenges and future prospects of nanomedicine-based stroke treatments.

BIOACTIVE MATERIALS (2021)

Article Pharmacology & Pharmacy

Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy

Ailing Zhang et al.

Summary: The liposomes containing biosurfactant sodium cholate (CA-liposomes) improved the oral delivery of NBP, showing advantages in terms of rapid drug release, high encapsulation efficiency, superior cell uptake, efficient transport, and high bioavailability. The NBP-loaded CA-liposomes demonstrated significant therapeutic efficacy in an animal model of ischemic stroke, providing potential for clinical application.

DRUG DELIVERY (2021)

Article Chemistry, Multidisciplinary

Macrophage-Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke

Chao Li et al.

Summary: This biomimetic nanomedicine utilizes macrophage-disguised manganese dioxide nanospheres loaded with fingolimod to target the damaged brain in ischemic stroke, reducing oxidative stress, promoting microglial transition, and ultimately enhancing neuronal survival. This new strategy offers a multitargeted combined treatment approach for ischemic stroke.

ADVANCED SCIENCE (2021)

Article Chemistry, Multidisciplinary

Biocompatible BSA-MnO2 nanoparticles for in vivo timely permeability imaging of blood-brain barrier and prediction of hemorrhage transformation in acute ischemic stroke

Wenjing Hou et al.

Summary: BM NPs, with high T-1 relaxivity and good biocompatibility, show potential as a biocompatible MR contrast agent for noninvasive BBB permeability imaging, allowing for timely visualization and prediction of HT onset in stroke patients.

NANOSCALE (2021)

Article Medicine, Research & Experimental

Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia

Tian Tian et al.

Summary: Ischemic stroke is a major cause of death and anti-inflammatory strategies are promising for reducing brain injury during reperfusion. Stem cell-derived extracellular vesicles (EVs) have emerged as therapeutic agents for immune modulation. By attaching targeting ligands onto EVs using a recombinant fusion protein, researchers were able to deliver anti-inflammatory EVs to the ischemic brain, showing promising results in suppressing inflammation.

THERANOSTICS (2021)

Article Materials Science, Biomaterials

Sivelestat-loaded nanostructured lipid carriers modulate oxidative and inflammatory stress in human dental pulp and mesenchymal stem cells subjected to oxygen-glucose deprivation

Ravi Prakash et al.

Summary: Despite almost two decades of clinical translation, stem cell-based therapies for stroke patients have not shown significant improvement. An amalgamation of nanocarriers with stem cells presents a promising approach to enhance stroke recovery.

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Article Pharmacology & Pharmacy

Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment

Xianfeng Lu et al.

Summary: The development of suitable drug delivery carriers is crucial for improving therapeutic efficiency, especially in treating brain disorders. This study synthesized a PLGA-functionalized magnetic nanoparticle carrier that can effectively penetrate the blood-brain barrier for treating ischemic stroke.

DRUG DELIVERY (2021)

Article Chemistry, Multidisciplinary

Liposomal 9-Aminoacridine for Treatment of Ischemic Stroke: From Drug Discovery to Drug Delivery

Haojie Wang et al.

NANO LETTERS (2020)

Article Geriatrics & Gerontology

Improved Neuroprotective Effects of Gallic Acid-Loaded Chitosan Nanoparticles Against Ischemic Stroke

Yongmei Zhao et al.

REJUVENATION RESEARCH (2020)

Review Engineering, Biomedical

Nanomedicine progress in thrombolytic therapy

Alina Zenych et al.

BIOMATERIALS (2020)

Article Multidisciplinary Sciences

Physiological blood-brain transport is impaired with age by a shift in transcytosis

Andrew C. Yang et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Nanomedicine for Ischemic Stroke

Xinyue Dong et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Pharmacology & Pharmacy

Natural biodegradable polymers based nano-formulations for drug delivery: A review

Archana George et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Review Chemistry, Multidisciplinary

Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system

Jinhwan Kim et al.

JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2019)

Review Nutrition & Dietetics

Influence of Resveratrol on the Immune Response

Lucia Malaguarnera

NUTRIENTS (2019)

Article Chemistry, Multidisciplinary

Recognition, Intervention, and Monitoring of Neutrophils in Acute Ischemic Stroke

Chunming Tang et al.

NANO LETTERS (2019)

Review Engineering, Biomedical

Natural Polymer-Based Hydrogels with Enhanced Mechanical Performances: Preparation, Structure, and Property

Ziting Bao et al.

ADVANCED HEALTHCARE MATERIALS (2019)

Review Chemistry, Medicinal

Therapies from Fucoidan: New Developments

J. Helen Fitton et al.

MARINE DRUGS (2019)

Review Engineering, Biomedical

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Jinbing Xie et al.

BIOMATERIALS (2019)

Review Biochemical Research Methods

Exploiting BBB disruption for the delivery of nanocarriers to the diseased CNS

Benjamin J. Umlauf et al.

CURRENT OPINION IN BIOTECHNOLOGY (2019)

Article Pharmacology & Pharmacy

Tissue plasminogen activator-based nanothrombolysis for ischemic stroke

Shan Liu et al.

EXPERT OPINION ON DRUG DELIVERY (2018)

Review Multidisciplinary Sciences

Therapeutic applications of betulinic acid nanoformulations

Ankit Saneja et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)

Article Biochemistry & Molecular Biology

Erythrocyte-Derived Nanoparticles as a Theranostic Agent for Near-Infrared Fluorescence Imaging and Thrombolysis of Blood Clots

Raviraj Vankayala et al.

MACROMOLECULAR BIOSCIENCE (2018)

Article Chemistry, Multidisciplinary

Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy

Xing Guo et al.

ACS NANO (2018)

Article Multidisciplinary Sciences

Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood-brain barrier

Nikolay Kutuzov et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Pharmacology & Pharmacy

Role of Passive Diffusion, Transporters, and Membrane Trafficking-Mediated Processes in Cellular Drug Transport

E. Cocucci et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

Review Biochemistry & Molecular Biology

Chitosan as a bioactive polymer: Processing, properties and applications

A. Muxika et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)

Review Materials Science, Biomaterials

Mechanical properties of PNIPAM based hydrogels: A review

Muhammad Abdul Haq et al.

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)

Review Biotechnology & Applied Microbiology

Vectorized nanodelivery systems for ischemic stroke: a concept and a need

Andres Da Silva-Candal et al.

JOURNAL OF NANOBIOTECHNOLOGY (2017)

Review Clinical Neurology

Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain

Mayur M. Patel et al.

CNS DRUGS (2017)

Review Chemistry, Analytical

Gallic Acid: Review of the Methods of Determination and Quantification

Felipe Hugo Alencar Fernandes et al.

CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY (2016)

Article Chemistry, Multidisciplinary

Dual targeted nanocarrier for brain ischemic stroke treatment

Yue Zhao et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Chemistry, Multidisciplinary

Nanostructured Antagonist of Extrasynaptic NMDA Receptors

Alex Saychenko et al.

NANO LETTERS (2016)

Article Nanoscience & Nanotechnology

Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles

Liang Han et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)

Article Multidisciplinary Sciences

B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity

Luisa Klotz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Medicine, Research & Experimental

In Vivo Theranostics at the Peri-Infarct Region in Cerebral Ischemia

Jesus Agulla et al.

THERANOSTICS (2014)

Article Instruments & Instrumentation

Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model

Elizabeth Joachim et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)

Article Chemistry, Multidisciplinary

Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood-Brain Barrier

Ruirui Qiao et al.

ACS NANO (2012)

Review Pharmacology & Pharmacy

Modern methods for delivery of drugs across the blood-brain barrier

Yan Chen et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Review Pharmacology & Pharmacy

Nanotechnological advances for the delivery of CNS therapeutics

Ho Lun Wong et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Review Endocrinology & Metabolism

Drug transport across the blood-brain barrier

William M. Pardridge

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Article Biotechnology & Applied Microbiology

Coexistence of passive and carrier-mediated processes in drug transport

Kiyohiko Sugano et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Neurosciences

Structure and function of the blood-brain barrier

N. Joan Abbott et al.

NEUROBIOLOGY OF DISEASE (2010)

Article Biotechnology & Applied Microbiology

Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse

Akihiko Urayama et al.

MOLECULAR THERAPY (2008)

Article Biochemistry & Molecular Biology

Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

H. Ryoung Kim et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2007)

Review Food Science & Technology

Starch-value addition by modification

RN Tharanathan

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2005)